Navigation Links
FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
Date:4/29/2010

Dendreon will donate funds to an independent non-profit organization that will provide financial assistance to patients who cannot afford the co-payments associated with their prostate cancer medicines. In addition, Dendreon's dedicated call center case managers will proactively help match patients with foundations to support their financial assistance needs.  

For more information, please visit www.PROVENGE.com.

Conference Call Information

Please be advised that Dendreon will not be hosting a first quarter financial results call.  

To access the live conference call, dial 1-866-788-0546 (domestic) or 857-350-1684 (international) participant passcode: 35405823. The call also will be audio webcast and will be available from the Company's website at www.dendreon.com under the "Investor/Webcasts and Presentations" section. There will be a slide presentation to accompany the call, which will also be available on this section of the Dendreon website. A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 888-286-8010 or 617-801-6888 (international); the participant pass code is 18379189. The replay will be available from April, 29 at 9:00 p.m. ET until May 13 at 11:59 p.m. ET. In addition, the webcast will be archived for on-demand listening for
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 The ... , Occupy Psychiatry , and ... health care, announces a social media campaign showcasing ... traditional psychiatric model, which focuses on pathology and ... coincides with the American Psychiatric Association,s (APA) rollout ...
(Date:5/17/2013)...  Lakeland Industries, Inc. (NASDAQ: LAKE ), ... healthcare and to first responders on the federal, state ... the fiscal 2013 fourth quarter and year ended January ... market close and will conduct a conference call on ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The call ...
(Date:5/17/2013)... May 17, 2013   Shareholder rights attorneys  at ... Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint ... Massachusetts .  The complaint alleges that ... Exchange Act of 1934 (the "Exchange Act") between January ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
(Date:5/20/2013)... Angeles, CA (PRWEB) May 20, 2013 Idol ... get bigger, thicker, darker and fuller eyelashes in a matter ... now available for online purchase with an extra pack offer ... Customers can easily access this offer on the Idol lash ... and showed to increase the eyelash density up to 82% ...
(Date:5/20/2013)... US Drug Watchdog says, "After talking with ... are now calling the transvaginal mesh failure issues the ... and the damages are literally beyond comprehension. We are ... women. According to the New York Times, in 2010, ... implanted vaginally to treat urinary incontinence. That was 2010 ...
(Date:5/20/2013)... 20, 2013 On May 14th, premiere ... testimonial about how one of its patients originally came ... after being diagnosed with giant papillary conjunctivitis. “Giant papillary ... the eye, and for one of our patients in ... allergy,” says the Medical Director of the Atlanta Vision ...
(Date:5/20/2013)... The Mesothelioma Victims Center says, "We are ... diagnosed with mesothelioma get shortchanged when it comes to ... members turned to a local personal injury law firm, ... and experienced mesothelioma lawyers in the nation. We also ... never even bother to explore their legal options, because ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... MessageSolution, an industry leader in enterprise-class information archiving, ... Enterprise eDiscovery Platform 7.0, the latest release in ... all facets of the legal discovery lifecycle. MessageSolution ... in Los Angeles CA. , As the first ...
Breaking Medicine News(10 mins):Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:Atlanta LASIK Practice Publishes a Patient’s Testimonial About Allergy to Contact Lenses 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4
... Allscripts (Nasdaq: MDRX ),the leading provider ... use to improve healthcare, announced today that,it will ... months ended September,30, 2007 after the stock market ... Eastern Standard Time on the same day, Allscripts ...
... HILL, N.C., Oct. 23 As companies transform ... with the art of selling while maintaining a ... in facilitating the changeover,the manager/supervisor is one of ... In fact, call center leaders recommend reducing ...
... For Minimizing Commercial Exposure To Microbes, CHARLOTTE, ... provider of commercial hygiene products and services, today,announced ... at the ISSA/Interclean,trade show in Orlando from October ... number of germ reduction strategies that have been ...
... Answers.com(TM) (NASDAQ:,ANSW) today announced that it ... HealthiNation, a leading digital health media ... (See example at, http://www.answers.com/topic/cholesterol .) Answers.com ... such as business,health, travel, technology, science, ...
... LOUIS, Oct. 23 Cejka Search, a ... recently,announced that several of its leaders will ... conferences: The Medical Group,Management Association (MGMA) 2007 ... (ACPE) Fall Institute and the American College ...
... - TimeToTalk.org Provides Parents Timely Tips and Tools to Keep Youth ... ... have numerous methods,to trick their parents and keep their social behavior secret ... and social functions can help teens shield their drug or alcohol,use from ...
Cached Medicine News:Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 3Health News:Call Center Excellence: Managing Service-To-Sales Cultural Transformation 2Health News:Swisher Launches Germ-Free Zone at ISSA 2Health News:Answers.com Adds HealthiNation Video Content to Answer Engine(TM) 2Health News:Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences 2Health News:Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences 3Health News:Don't Be 'Tricked' By Your Teen This Month - It's Time To Talk With Teens About Drug and Alcohol Use 2Health News:Don't Be 'Tricked' By Your Teen This Month - It's Time To Talk With Teens About Drug and Alcohol Use 3Health News:Don't Be 'Tricked' By Your Teen This Month - It's Time To Talk With Teens About Drug and Alcohol Use 4
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts...
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
Seletz-Gelpi Laminectomy Retractor, self-retaining with arms bent at right angles....
Scoville-Haverfield Hemilaminectomy Retractor...
Medicine Products: